U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C21H25ClN2O4S
Molecular Weight 436.952
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TIANEPTINE

SMILES

CN1C2=C(C=CC=C2)C(NCCCCCCC(O)=O)C3=CC=C(Cl)C=C3S1(=O)=O

InChI

InChIKey=JICJBGPOMZQUBB-UHFFFAOYSA-N
InChI=1S/C21H25ClN2O4S/c1-24-18-9-6-5-8-16(18)21(23-13-7-3-2-4-10-20(25)26)17-12-11-15(22)14-19(17)29(24,27)28/h5-6,8-9,11-12,14,21,23H,2-4,7,10,13H2,1H3,(H,25,26)

HIDE SMILES / InChI

Molecular Formula C21H25ClN2O4S
Molecular Weight 436.952
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

TIANEPTINE, a tricyclic antidepressant, is a drug used for the treatment of the major depressive disorder. It was discovered by The French Society of Medical Research in the 1980s. Unlike other tricyclic antidepressants, TIANEPTINE is a selective serotonin reuptake enhancer with minimal effects on norepinephrine and dopamine uptake. Also, it is a full agonist at the mu-opioid and delta-opioid receptors with no effect at the kappa-opioid receptors. Selective mu-opioid agonists typically induce euphoria, which may contribute to TIANEPTINE's antidepressant effect. It is marketed as Coaxil/Stablon in many European countries, but it is not available in the US.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P35372|||G8XRH8|||Q5TDA1|||Q9UN57
Gene ID: 4988.0
Gene Symbol: OPRM1
Target Organism: Homo sapiens (Human)
383.0 nM [Ki]
PubMed

PubMed

TitleDatePubMed
Tianeptine: a review of its use in depressive disorders.
2001
Effects of tianeptine and mianserin on car driving skills.
2001 Apr
Current trends in the development of new antidepressants.
2001 Feb
Tianeptine versus fluoxetine in the treatment of depression complicating Alzheimer's disease.
2001 Nov
Asthma, asthma medication and autonomic nervous system dysfunction.
2001 Nov
[The role of depressive disorders in hypertensive disease and possibilities of their correction: assessment of the effect of tianeptine].
2002
[The level of 8-iso-prostaglandin F2 alpha, 4-hydroxynonenal and malondialdehyde in alcohol dependent men during combined therapy].
2002
Tianeptine and fluoxetine in major depression: a 6-week randomised double-blind study.
2002 Aug
The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression.
2002 Dec
Mss4 gene is up-regulated in rat brain after chronic treatment with antidepressant and down-regulated when rats are anhedonic.
2002 Dec
A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression.
2002 Jul
Structural plasticity and tianeptine: cellular and molecular targets.
2002 Jul
[Efficacy and acceptability of tianeptine and sertraline in the acute treatment phase of depression].
2002 Jul-Aug
Enhancement of stress-induced pituitary hormone release and cardiovascular activation by antidepressant treatment in healthy men.
2002 Sep
[Therapy of affective disorders with tianeptine in patients with essential hypertension].
2003
The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France.
2003
Psychopharmacological effects of tianeptine analogous hetero[2,1] benzothiazepine derivatives.
2003
State markers of depression in sleep EEG: dependency on drug and gender in patients treated with tianeptine or paroxetine.
2003 Feb
Neuropharmacological study of hetero[2,1]benzothiazepine derivatives analogues of tianeptine.
2003 Jan
Tianeptine may be a useful adjunct in the treatment of alcohol dependence of adolescents.
2003 Jan
Chronic treatment with the antidepressant tianeptine attenuates lipopolysaccharide-induced Fos expression in the rat paraventricular nucleus and HPA axis activation.
2003 Jan
Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity.
2003 Jan 3
Tianeptine, plasma serotonin, and pulmonary hypertension.
2003 Jan 4
Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice.
2003 Jul
Switching to tianeptine in patients with antidepressant-induced sexual dysfunction.
2003 Jun
[Therapy resistant major depression: improvement of symptomatology after combining antidepressants with Tianeptine (Stablon)].
2003 May
[Misuse of tianeptine: five cases of abuse].
2003 Nov
Prenatal stress in rats predicts immobility behavior in the forced swim test. Effects of a chronic treatment with tianeptine.
2003 Nov 7
[Does addiction to antidepressants exist? About a case of one addiction to tianeptine].
2003 Sep-Oct
[Clinical efficacy of tianeptine in patients with ischemic heart disease and comorbid depression].
2004
Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseases.
2004
Trends in the development of new antidepressants. Is there a light at the end of the tunnel?
2004 Apr
Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex.
2004 Apr 15
Tianeptine: a new exploratory therapy for asthma.
2004 Jan
Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats.
2004 Jul
Treatment of bronchial asthma with tianeptine.
2004 Nov
Differential regulation of variant glucocorticoid receptor mRNAs in the rat hippocampus by the antidepressant fluoxetine.
2004 Oct 22
[Comparison of two assessment tools of antidepressant side-effects: UKU scale versus spontaneous notification].
2004 Sep-Oct
Neuroendocrine predictors of the evolution of depression.
2005
[Coaxil treatment of primary headaches comorbid with depression].
2005
Treatment of depression with the serotonin reuptake enhancer tianeptine in the primary care setting of India.
2005 Feb
Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments.
2006 Feb 1
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.
2006 Jan 27
Patents

Patents

Sample Use Guides

Using radioligand binding and cell-based functional assays, including bioluminescence resonance energy transfer-based assays for G-protein activation and cAMP accumulation, tianeptine was identified as an efficacious mu-opioid receptor agonist (Ki of 383+/-183 nM and EC50 of 194+/-70 nM). Tianeptine was also a full delta-opioid receptor agonist, although with much lower potency (EC50 of 37.4+/-11.2 uM for G-protein activation). In contrast, tianeptine was inactive at the kappa-opioid receptor.
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:47:15 GMT 2023
Edited
by admin
on Sat Dec 16 16:47:15 GMT 2023
Record UNII
0T493YFU8O
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TIANEPTINE
INN   MI   WHO-DD  
INN  
Official Name English
STABLON
Brand Name English
JNJ-39823277
Code English
(3-CHLORO-6-METHYL-5,5-DIOXO-6,11-DIHYDRODIBENZO(C,F)(1,2)THIAZEPIN-11-YL)-7-AMINOHEPTANOIC ACID
Systematic Name English
TPI-1062
Code English
7-((3-CHLORO-6,11-DIHYDRO-6-METHYLDIBENZO(C,F)(1,2)THIAZEPIN-11-YL)AMINO)HEPTANOIC ACID S,S-DIOXIDE
Common Name English
tianeptine [INN]
Common Name English
TIANEPTINE [MI]
Common Name English
Gas station heroin
Common Name English
Tianeptine [WHO-DD]
Common Name English
TIANEPTINE [NFLIS-DRUG]
Common Name English
S-1574
Code English
Classification Tree Code System Code
NCI_THESAURUS C265
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
WHO-ATC N06AX14
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
FDA ORPHAN DRUG 627918
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
WIKIPEDIA Designer-drugs-Tianeptine
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
WHO-VATC QN06AX14
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
NCI_THESAURUS C28197
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
Code System Code Type Description
DRUG CENTRAL
2650
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY
MERCK INDEX
m10845
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY Merck Index
EVMPD
SUB11007MIG
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY
SMS_ID
100000082178
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY
IUPHAR
7558
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY
EPA CompTox
DTXSID7048295
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY
PUBCHEM
68870
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY
ChEMBL
CHEMBL1289110
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY
CAS
72797-41-2
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY
INN
4906
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY
CAS
66981-73-5
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
SUPERSEDED
FDA UNII
0T493YFU8O
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY
NCI_THESAURUS
C152599
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY
MESH
C050504
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY
RXCUI
38252
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY RxNorm
DRUG BANK
DB09289
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY
WIKIPEDIA
TIANEPTINE
Created by admin on Sat Dec 16 16:47:16 GMT 2023 , Edited by admin on Sat Dec 16 16:47:16 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
ENANTIOMER -> RACEMATE
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
TARGET -> AGONIST
Ki
TARGET -> AGONIST
Atypical. G-protein activation
EC50
SALT/SOLVATE -> PARENT
ENANTIOMER -> RACEMATE
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY